A detailed history of Chase Investment Counsel Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Chase Investment Counsel Corp holds 8,781 shares of MEDP stock, worth $3.53 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
8,781
Previous 9,676 9.25%
Holding current value
$3.53 Million
Previous $2.97 Million 19.66%
% of portfolio
1.36%
Previous 1.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$284.87 - $413.31 $254,958 - $369,912
-895 Reduced 9.25%
8,781 $3.55 Million
Q4 2023

Feb 05, 2024

SELL
$227.52 - $312.68 $39,360 - $54,093
-173 Reduced 1.76%
9,676 $2.97 Million
Q3 2023

Nov 08, 2023

BUY
$233.98 - $281.67 $70,427 - $84,782
301 Added 3.15%
9,849 $2.38 Million
Q2 2023

Jul 28, 2023

BUY
$187.26 - $240.17 $1.79 Million - $2.29 Million
9,548 New
9,548 $2.29 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.